Actuate Therapeutics, Inc. (ACTU)

CIK 1652935 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Actuate Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001683168-26-006472
Aug 14, 202640001683168-26-006493
Jul 17, 20268-K0001683168-26-005616
May 22, 20268-K0001683168-26-004268
May 22, 202640001683168-26-004257
May 22, 202640001683168-26-004245
May 22, 202640001683168-26-004241
May 22, 202640001683168-26-004255
May 22, 202640001683168-26-004243
May 22, 202640001683168-26-004260
May 22, 202640001683168-26-004251
May 14, 2026S-80001683168-26-003915
May 14, 202610-Q0001683168-26-003909
May 11, 20268-K0001683168-26-003684
May 6, 2026DEFA14A0001683168-26-003517
May 6, 202630001683168-26-003533
May 6, 20268-K0001683168-26-003515
Apr 22, 2026SCHEDULE 13G/A0002060757-26-000023
Apr 9, 2026ARS0001683168-26-002780
Apr 6, 2026DEF 14A0001683168-26-002691
Apr 6, 2026DEFA14A0001683168-26-002692
Apr 1, 202640001683168-26-002580
Apr 1, 202640001683168-26-002582
Apr 1, 202640001683168-26-002581
Mar 26, 202610-K0001683168-26-002257